Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives

M Sobczak, M Sałaga, MA Storr, J Fichna - Journal of gastroenterology, 2014 - Springer
Opioid receptors are widely distributed in the human body and are crucially involved in
numerous physiological processes. These include pain signaling in the central and the …

Opioid receptors and cardioprotection–'opioidergic conditioning'of the heart

JP Headrick, LE See Hoe, EF Du Toit… - British journal of …, 2015 - Wiley Online Library
Ischaemic heart disease (IHD) remains a major cause of morbidity/mortality globally, firmly
established in W esternized or 'developed'countries and rising in prevalence in developing …

The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms

H Najafipour, A Beik - Frontiers in physiology, 2016 - frontiersin.org
Aim: Substance abuse has become a universal crisis in our modern age. Among illegal
substances, opium and its derivatives have been ranked second in terms of usage after …

Peripherally acting μ-opioid receptor antagonists for the treatment of opioid-related side effects: mechanism of action and clinical implications

JM Streicher, EJ Bilsky - Journal of pharmacy practice, 2018 - journals.sagepub.com
Opioid receptors are distributed throughout the central and peripheral nervous systems and
on many nonneuronal cells. Therefore, opioid administration induces effects beyond …

Codeine exerts cardiorenal injury via upregulation of adenine deaminase/xanthine oxidase and caspase 3 signaling

RE Akhigbe, LO Ajayi, AF Ajayi - Life Sciences, 2021 - Elsevier
Aims Codeine treatment has been shown to be associated with glucolipid deregulation,
though data reporting this are inconsistent and the mechanisms are not well understood …

Positive social interactions in a lifespan perspective with a focus on opioidergic and oxytocinergic systems: Implications for neuroprotection

V Colonnello, N Petrocchi, M Farinelli… - Current …, 2017 - ingentaconnect.com
In recent years, a growing interest has emerged in the beneficial effects of positive social
interactions on health. The present work aims to review animal and human studies linking …

Opioids in cardiovascular disease: therapeutic options

H Rawal, BM Patel - Journal of Cardiovascular …, 2018 - journals.sagepub.com
The World Health Organization suggests that the cardiovascular diseases (CVDs) are the
major cause of mortality and account for two-thirds of the deaths all over the world. These …

Incidence and Health Related Quality of Life of Opioid‐Induced Constipation in Chronic Noncancer Pain Patients: A Prospective Multicentre Cohort Study

DR Veiga, L Mendonça, R Sampaio… - Pain research and …, 2018 - Wiley Online Library
Background. High rates of opioid use for chronic noncancer pain (CNCP) have been
reported worldwide, despite its association with adverse events, inappropriate use, and …

Endogenous cardioprotective agents: role in pre and postconditioning

C Penna, R Granata, C Gabriele Tocchetti… - Current drug …, 2015 - ingentaconnect.com
Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability
in Western countries. The most common cause of CVD derives from the harmful effects of …

Inhibition of the protective effects of preconditioning in ischemia–reperfusion injury by chronic methadone: the role of pAkt and pSTAT3

M Yeganeh-Hajahmadi, Z Kordestani… - Scientific Reports, 2024 - nature.com
Cardiac ischemic preconditioning (Pre) reduces cardiac ischemia–reperfusion injury (IRI) by
stimulating opioid receptors. Chronic use of opioids can alter the signaling pathways. We …